Business Context and Reporting Period
Company: Channel Therapeutics Corporation (Note: Input metadata referenced "Pelthos Therapeutics Inc." but the filing text identifies the registrant as Channel Therapeutics Corporation, trading as CHRO on NYSE American).
Filing Type: Form 8-K (Current Report)
Reporting Date: February 25, 2025
Event: Entry into a Material Definitive Agreement involving the issuance of an unsecured promissory note.
Key Financial Metrics
This filing reports a specific financing transaction rather than periodic financial performance. Key metrics related to the transaction include:
- Principal Amount: $325,000
- Purchase Price (Cash Received): $250,000
- Interest Rate: 6.0% per annum on outstanding principal
- Debt Instrument: Unsecured promissory note
- Lender: 3i, L.P.
The filing text does not provide clear values for total revenue, net profit, operating cash flow, gross margins, total debt, or overall liquidity positions outside of this specific transaction.
Material Changes
The primary material change is the creation of a new direct financial obligation. The Company incurred a liability of $325,000 in exchange for $250,000 in immediate liquidity. This represents a discount issuance where the difference between the principal and purchase price ($75,000) effectively acts as upfront financing cost or discount.
Outlook, Risks, and Terms
Repayment Terms: The note is due on the earliest of:
- May 25, 2025
- Consummation of a "Corporate Event" (as defined in the Note)
- Occurrence of an "Event of Default"
Prepayment: The Company may prepay the note in whole or in part without penalty upon two days' prior written notice.
Risks: The obligation is unsecured. Failure to repay by the maturity date or upon a Corporate Event/Default could trigger immediate acceleration of the debt.
Management Commentary: The filing contains no additional management commentary or forward-looking guidance beyond the terms of the note.
Investor Verification Checklist
- Verify the definition of "Corporate Event" in the attached Exhibit 10.1 to understand potential early repayment triggers.
- Confirm the Company's current cash position to assess ability to repay the $325,000 principal by May 25, 2025.
- Review the "Event of Default" clauses in the promissory note to identify specific covenants or conditions that could accelerate the debt.
- Check subsequent filings for any amendments to the note or additional debt issuances.